샘플 요청 목록

 카트 문의
시장보고서
상품코드
1788305

세계의 폐 스텐트 시장

Pulmonary Stents
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 170 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 폐 스텐트 시장은 2030년까지 3억 3,110만 달러에 달할 전망

2024년에 2억 4,880만 달러로 추정되는 세계의 폐 스텐트 시장은 2024-2030년에 CAGR 4.9%로 성장하며, 2030년에는 3억 3,110만 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 자기 확장형 스텐트는 CAGR 5.8%를 기록하며, 분석 기간 종료시에는 2억 2,150만 달러에 달할 것으로 예측됩니다. 풍선 확장형 스텐트 부문의 성장률은 분석 기간 중 CAGR 3.2%로 추정됩니다.

미국 시장은 6,540만 달러로 추정, 중국은 CAGR 4.7%로 성장 예측

미국의 폐 스텐트 시장은 2024년에 6,540만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 5,320만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 4.7%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 4.6%와 4.2%로 예측됩니다. 유럽에서는 독일이 CAGR 3.9%로 성장할 것으로 예측됩니다.

세계 폐 스텐트 시장 - 주요 동향 및 촉진요인 요약

폐 스텐트가 호흡기 의료에 필수적인 이유는 무엇인가?

폐 스텐트는 기관지 협착, 폐암, 만성폐쇄성폐질환(COPD), 수술 후 합병증 등의 질환으로 인한 기도폐쇄 관리에 중요한 역할을 하고 있습니다. 이 스텐트는 기도의 개방성을 유지하여 환자의 호흡을 돕고 전반적인 삶의 질을 향상시키는 데 도움이 됩니다. 환경오염, 흡연, 고령화로 인해 호흡기 질환의 유병률이 지속적으로 증가함에 따라 폐 스텐트 수요가 크게 증가하고 있습니다. 침습적 수술과 달리 기관지경 스텐트 삽입술은 최소 침습적 솔루션을 제공하여 환자의 회복 시간과 입원 기간을 단축시킵니다. 호흡기 치료에서 수술이 필요 없는 치료법이 선호되면서 폐 스텐트 기술의 발전이 촉진되어 보다 효과적이고 내구성이 뛰어난 생체적합성 스텐트가 개발되고 있습니다. 의료진은 복잡한 호흡기 질환을 관리하기 위한 치료 프로토콜에 폐 스텐트를 점점 더 많이 도입하고 있으며, 전 세계 병원과 전문 클리닉에서 폐 스텐트 사용이 확대되고 있습니다.

기술의 발전으로 폐 스텐트의 성능은 어떻게 향상되고 있는가?

최근 폐 스텐트 설계 및 재료의 기술 혁신으로 임상 효과와 환자 예후가 크게 향상되었습니다. 기존의 금속 스텐트나 실리콘 스텐트는 전이 위험을 최소화하고 기도내 장기적인 안정성을 향상시키기 위해 개선되어 왔습니다. 기도의 윤곽에 적응하고 잦은 위치 변경의 필요성을 줄여주는 자가 확장형 스텐트의 도입으로 시술의 성공률을 향상시켰습니다. 또한 항염증약나 항증식제로 코팅된 약제용출성 스텐트는 재협착을 예방하고 반복적인 중재시술의 가능성을 줄이기 위해 개발되고 있습니다. 시간이 지남에 따라 서서히 용해되는 생체흡수성 스텐트는 일시적인 기도 지원을 위한 유망 대안으로 부상하고 있으며, 스텐트 제거 시술의 필요성을 없애고 있습니다. 또한 고해상도 CT 스캔, 유도하 기관지경 등 영상기술의 향상으로 스텐트 삽입의 정확도가 향상되고 합병증이 감소하여 치료결과가 최적화되고 있습니다. 스텐트의 유연성, 생체적합성 및 장기적 유효성 향상에 초점을 맞춘 연구가 계속되고 있으며, 차세대 폐 스텐트는 호흡기 의학의 새로운 표준을 제시할 것으로 기대됩니다.

폐 스텐트 채택을 촉진하는 요인은 무엇인가?

폐 질환의 유병률 증가와 저침습적 치료 옵션에 대한 인식이 높아지면서 폐 스텐트에 대한 수요가 증가하고 있습니다. 환자와 의료진들은 기관지경하 스텐트 삽입술이 기존의 개복 수술보다 위험성이 낮고 회복이 빠르며 환자의 편의성이 향상되어 기존 개복 수술보다 기관지경하 스텐트 삽입술을 선호하고 있습니다. 특히 고령화 사회에서 폐암 발병률 증가는 기도 관리 솔루션의 필요성을 더욱 가속화시키고 있으며, 폐 스텐트는 진행성 암 환자의 완화치료에 널리 사용되고 있습니다. 또한 대기오염과 흡연 습관으로 인한 COPD 환자가 전 세계에서 증가함에 따라 기도 폐쇄를 효과적으로 관리하기 위한 스텐트 삽입이 증가하고 있습니다. 금속과 실리콘의 장점을 결합한 하이브리드 디자인 등 스텐트 제조의 기술적 진보도 내구성과 기능성을 향상시켜 시장 성장에 기여하고 있습니다. 많은 선진국에서 폐중재에 대한 상환 정책을 이용할 수 있는 것은 병원과 전문 클리닉이 기도 관리를 위해 이러한 장치를 채택하는 것을 더욱 촉진하고 있습니다.

폐 스텐트 시장의 성장을 가속하는 주요 요인은?

세계 폐 스텐트 시장의 성장은 만성 호흡기 질환의 유병률 증가, 스텐트 설계 및 재료의 발전, 저침습적 기도 관리 기술의 채택 증가 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 특히 신흥 시장의 의료 인프라 확대는 고급 호흡기 치료에 대한 접근성을 향상시켜 폐 스텐트에 대한 수요를 증가시키고 있습니다. 또한 AI를 활용한 영상처리와 로봇 보조 기관지경의 통합으로 시술의 정확도가 향상되고, 스텐트 삽입이 보다 효과적으로 이루어지며, 합병증 발생률이 감소하고 있습니다. 또한 의료 서비스 프로바이더, 연구 기관 및 의료기기 제조업체의 호흡기 치료에 대한 투자 확대는 폐 스텐트 기술의 혁신을 가속화하고 있습니다. 차세대 스텐트에 대한 규제 당국의 승인은 의료기기 제조업체와 의료 기관과의 협력 관계 증가와 함께 시장 확대를 더욱 촉진하고 있습니다. 효과적인 기도 관리 솔루션에 대한 수요가 지속적으로 증가함에 따라 폐 스텐트 시장은 호흡기 치료의 미래를 형성하는 지속적인 발전과 함께 지속적으로 발전할 태세를 갖추고 있습니다.

부문

제품(자기 확장형 스텐트, 풍선 확장형 스텐트), 재료(금속, 실리콘, 하이브리드), 유형(기관 기관지 스텐트, 후두 스텐트)

조사 대상 기업의 예

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.(Cordis)
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • M.I. Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech(Nanjing) Co., Ltd.

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.08.18

Global Pulmonary Stents Market to Reach US$331.1 Million by 2030

The global market for Pulmonary Stents estimated at US$248.8 Million in the year 2024, is expected to reach US$331.1 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Self-expandable Stents, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$221.5 Million by the end of the analysis period. Growth in the Balloon-expandable Stents segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.4 Million While China is Forecast to Grow at 4.7% CAGR

The Pulmonary Stents market in the U.S. is estimated at US$65.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$53.2 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Pulmonary Stents Market - Key Trends & Drivers Summarized

Why Are Pulmonary Stents Becoming Essential in Respiratory Medicine?

Pulmonary stents play a crucial role in managing airway obstruction caused by conditions such as tracheobronchial stenosis, lung cancer, chronic obstructive pulmonary disease (COPD), and post-surgical complications. These stents help maintain airway patency, allowing patients to breathe more easily and improving overall quality of life. As the prevalence of respiratory disorders continues to rise due to environmental pollution, smoking, and aging populations, the demand for pulmonary stents has grown significantly. Unlike invasive surgical procedures, stent placement via bronchoscopy offers a minimally invasive solution, reducing patient recovery time and hospital stays. The increasing preference for non-surgical interventions in respiratory care has driven advancements in pulmonary stent technology, making them more effective, durable, and biocompatible. Healthcare providers are increasingly incorporating pulmonary stents into treatment protocols to manage complex airway diseases, leading to expanded adoption across hospitals and specialty clinics worldwide.

How Are Technological Advancements Improving Pulmonary Stent Performance?

Recent innovations in pulmonary stent design and materials have significantly enhanced their clinical efficacy and patient outcomes. Traditional metal and silicone stents have been refined to minimize migration risks and improve long-term stability within the airways. The introduction of self-expanding stents, which adapt to airway contours and reduce the need for frequent repositioning, has improved procedural success rates. Furthermore, drug-eluting pulmonary stents, coated with anti-inflammatory or anti-proliferative agents, are being developed to prevent restenosis and reduce the likelihood of repeat interventions. Bioresorbable stents, which gradually dissolve over time, are emerging as a promising alternative for temporary airway support, eliminating the need for stent removal procedures. Enhanced imaging technologies such as high-resolution CT scans and guided bronchoscopy have also improved the precision of stent placement, reducing complications and optimizing treatment outcomes. As research continues to focus on improving stent flexibility, biocompatibility, and long-term efficacy, the next generation of pulmonary stents is expected to set new standards in respiratory medicine.

What Factors Are Driving the Adoption of Pulmonary Stents?

The increasing prevalence of lung diseases, coupled with rising awareness about minimally invasive treatment options, has fueled the demand for pulmonary stents. Patients and healthcare providers are favoring bronchoscopic stenting over traditional open surgeries due to lower risks, faster recovery times, and improved patient comfort. The rising incidence of lung cancer, particularly in aging populations, has further accelerated the need for airway management solutions, with pulmonary stents being widely used for palliative care in advanced-stage cancer patients. Additionally, the growing number of COPD cases worldwide, driven by air pollution and smoking habits, has led to increased stent placements to manage airway obstruction effectively. Technological advancements in stent manufacturing, such as hybrid designs that combine the benefits of metal and silicone, are also contributing to market growth by offering enhanced durability and functionality. The availability of reimbursement policies for pulmonary interventions in many developed countries is further encouraging hospitals and specialty clinics to adopt these devices for airway management.

What Are the Key Drivers Fueling Growth in the Pulmonary Stents Market?

The growth in the global pulmonary stents market is driven by several key factors, including the rising incidence of chronic respiratory diseases, advancements in stent design and materials, and the increasing adoption of minimally invasive airway management techniques. The expansion of healthcare infrastructure, particularly in emerging markets, is improving access to advanced respiratory treatments, boosting demand for pulmonary stents. The integration of AI-powered imaging and robotic-assisted bronchoscopy is also enhancing procedural accuracy, making stent placement more effective and reducing complication rates. Furthermore, the growing investment in respiratory care by healthcare providers, research institutions, and medical device manufacturers is accelerating innovation in pulmonary stent technology. Regulatory approvals for next-generation stents, along with increasing collaborations between medical device companies and healthcare organizations, are further driving market expansion. As the demand for effective airway management solutions continues to grow, the pulmonary stents market is poised for sustained development, with ongoing advancements shaping the future of respiratory care.

SCOPE OF STUDY:

The report analyzes the Pulmonary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Self-expandable Stents, Balloon-expandable Stents); Material (Metal, Silicon, Hybrid); Type (Tracheobronchial Stents, Laryngeal Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc. (Cordis)
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • M.I. Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech (Nanjing) Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pulmonary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Tracheobronchial Obstructions and Airway Stenosis Throws the Spotlight on Pulmonary Stent Utilization
    • Expansion of Interventional Pulmonology and Minimally Invasive Airway Management Drives Adoption of Pulmonary Stents
    • Increasing Prevalence of COPD, Lung Cancer, and Post-Intubation Stenosis Strengthens Business Case for Airway Stenting
    • Advancements in Stent Design, Flexibility, and Radial Force Propel Innovation in Customized Pulmonary Stents
    • Surge in Geriatric Population and Age-Related Respiratory Disorders Drives Demand for Long-Term Airway Patency Solutions
    • Development of Drug-Eluting and Bioabsorbable Pulmonary Stents Expands the Therapeutic Scope for Chronic Pulmonary Conditions
    • Rising Adoption of 3D Printing and Patient-Specific Stent Models Enhances Procedural Precision and Clinical Outcomes
    • Integration of Bronchoscopic Navigation and Imaging Systems Improves Placement Accuracy and Procedural Safety
    • Growing Use of Temporary and Removable Silicone Stents Spurs Preference for Less Invasive and Reversible Airway Interventions
    • Regulatory Approvals and Reimbursement Policies Supporting Interventional Pulmonary Devices Propel Market Penetration
    • Increased Focus on Airway Rescue and Palliative Interventions in Advanced-Stage Oncology Boosts Pulmonary Stent Procedures
    • Emergence of Customized Hybrid Stents Combining Metal and Polymer Components Enhances Functional Performance
    • Collaborations Between Pulmonologists and Thoracic Surgeons Drive Adoption of Multidisciplinary Airway Management Approaches
    • Expansion of Specialized Centers for Complex Airway Disorders Spurs Training and Procedural Volumes Globally
    • Surging Demand for Pediatric Airway Stents Creates Opportunities for Miniaturized and Growth-Adaptive Device Designs
    • Focus on Reducing Granulation Tissue Formation and Migration Complications Drives Next-Generation Stent Development
    • Growth of Ambulatory Bronchoscopy Services Accelerates Use of Pulmonary Stents in Outpatient Settings
    • Rising Use of Pulmonary Stents in Emergency Airway Obstruction Scenarios Fuels Demand for Rapid-Deployment Systems
    • Investment in Clinical Trials and Real-World Evidence Collection Strengthens Regulatory Support and Market Confidence
    • Integration of Pulmonary Stents with Adjunctive Therapies Like Radiation and Chemotherapy Expands Multimodal Treatment Models
    • Expansion into Emerging Markets with Rising Respiratory Disease Burden Sustains Global Demand for Pulmonary Stenting Solutions
    • Focus on Sustainable Manufacturing and Biocompatible Materials Supports Eco-Efficient and Patient-Centric Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pulmonary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Self-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Balloon-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Silicon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Silicon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tracheobronchial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Tracheobronchial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Laryngeal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Laryngeal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • JAPAN
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CHINA
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • EUROPE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • FRANCE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • GERMANY
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제